Pigmentation Disorders Treatment Market – Growth, Trends, COVID-19 Impact and Forecast (2021 .)


The global pigmentation disorder treatment market was valued at $5,591. 98 million in 2020, and it is expected to reach $8,593. 68 million by 2026, growing at a CAGR of 7.14% over the forecast period.

New York, July 1, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the report “Pigmentation Disorders Treatment Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” – https://www.reportlinker.com/p06101229/?utm_source=GNW

The COVID-19 is impacting the pigmentation disorder treatment market. According to a survey by Hamilton Fraser Cosmetic Insurance, in March 2020, 1,360 estheticians in the UK to assess the impact of the pandemic said 99.78% said their practice had been affected by the pandemic outbreak. During the COVID-19 crisis, it is necessary to triage the patients and avoid unnecessary admissions, related to minor traumas and other ailments. It is also necessary not to call the patients to the hospital as much as possible, for regular check-ups and minor problems. While non-emergency clinics and surgical procedures should be postponed until the situation improves, the hospital must ensure the quality of patient care. Since most cosmetic procedures can be classified as non-essential, the market under investigation has been greatly affected.

The growth of the global pigmentation disorder treatment market is attributed to factors such as the increasing prevalence of pigmentation disorders along with the growing expenditure on dermatological treatments.

Typical pigmentation disorders include post-inflammatory hyperpigmentation, melasma, solar lentigines, ephelides (freckles), vitiligo, and café au lait macules. These conditions are generally benign, but can be distressing for patients.

A proper dermatologic history, skin exam, and skin biopsy can help rule out melanoma and its precursors. In addition to addressing the underlying condition, pigmentation disorders are treated with topical agents, chemical peels, cryotherapy, light or laser therapy, or a combination of these methods.

According to a research paper published in the International Journal of Molecular Sciences in 2018, a high prevalence of pigmentation disorders has been reported in dark-skinned people (South/Southeast Asian, Hispanic, African descent). Also, pigmentation disorders are the third and fourth most common dermatoses in blacks and Hispanics, respectively. Thus, the high prevalence of pigmentation disorders is expected to drive the market. In addition, increasing product launches are also driving market growth. For example, in February 2020, PCA SKIN reinvented two of its most popular chemical peels and added a new chemical peel intended solely for physicians, making it the most comprehensive portfolio of professional peels.

Thus, due to the above factors, the studied market is expected to experience significant growth over the forecast period. However, the high cost of cosmetic procedures and the inadequate reimbursement policies are expected to hinder the growth of the market under investigation over the forecast period.

Key Market Trends
The topical treatment segment is expected to have significant market share over the forecast period

Currently, the topical treatment segment dominates the global market due to its improved clinical outcomes in patients suffering from pigmentation disorders. The most common topical drugs prescribed worldwide are azelaic acid, hydroquinone, L-ascorbic acid, etc. Topical treatment involves topical application of creams, lotions, ointments and serums formulated with different active ingredients to treat different pigmentation conditions.

According to the National Clinical Trials (NCT) registry, Incyte Corporation is conducting a clinical trial on June 18, 2020 for Ruxolitinib for the treatment of vitiligo, which is in Phase II development in the United States. This factor will boost the market if the Ruxolitinib drug is approved for the treatment of vitiligo in the near future.

In addition, the application of topical corticosteroids (TC) to treat pigmentation disorders is one of the most successful treatment options. Some of the commonly used corticosteroids include fluticasone propionate, betamethasone valerate, and hydrocortisone butyrate.

According to the February 2021 research paper published in the Journal of Investigative Dermatology titled “Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo,” the results showed that twice-daily use of tacrolimus 0.1% ointment showed superior efficacy by 65% therapeutic success in 42 tacrolimus-treated patients.

According to the June 2019 research paper published on SCIENCE DAILY by researchers at Tufts Medical Center in Boston, the results showed that topical ruxolitinib cream was extremely effective in reversing the effects of vitiligo. The development of these therapies holds the promise of increasing the accessibility of an effective, non-invasive treatment option for hand tremors. So all these developments that are happening in the market right now are expected to bring huge growth opportunities to the segment.

The chart below suggests that population aging is increasing in different parts of the world. As the aging process alters the pigment system, uneven pigmentation is one of the major changes associated with aging, which can lead to increased demand for topical treatments in an aging population.

North America is expected to dominate the global pigmentation disorder treatment market

North America dominates the global pigmentation disorder treatment market due to increasing pigmentation disorders. Presence of an established healthcare infrastructure and major market players providing effective treatment options to patients suffering from post-inflammatory hyperpigmentation in North America. According to the 2018 National Organization for Albinism and Hypopigmentation, about one in 18,000 to 20,000 people in the United States had some form of albinism. In other parts of the world, the incidence can be as high as one in 3,000.

For example, according to the National Clinical Trials (NCT) Registry, as of June 21, 2021, there were 19 vitiligo-related trials under development in the United States (with statuses of “Active, Not Soliciting”, “Enroll by Invite” and “ Recruiting,” which is expected to have a positive impact on the market under investigation. As vitiligo is a common skin pigmentation disorder, increasing studies are expected to reveal more treatment options, supporting demand.

Moreover, the presence of some of the leading market players such as Obagi Cosmeceuticals, Alvogen and AbbVie Inc. is expected to drive the market growth due to the availability of various products. Various strategies, such as research and development, mergers and acquisitions and product launches, are adopted by domestic companies to strengthen their market position. In January 2020, Eli Lilly signed a definitive agreement to acquire dermatologic drug developer Dermira in a $1.1 billion cash deal, adding commercial and late-stage drugs to its portfolio. This is expected to boost the pipeline for dermatological treatments. Thus, the pigmentation disorder treatment market in the North American region is expected to grow at a decent pace over the forecast period.

Competitive landscape
The market for treatment of pigmentation disorders is fragmented and competitive. The key players are focused on expanding their business in different areas by adopting different market strategies such as partnerships, collaborations, acquisitions and mergers, etc. Key developments in the market include in July 2019 Dermatix, a brand of A .Menarini Singapore Pte Ltd has just launched its new acne scar care, Dermatix Acne Scar consisting of snail mucus extract and hyaluronic acid to combat skin discoloration after acne. The treatment gel contains Niacinamide (Vitamin B3) to reduce hyperpigmentation.

Reasons to purchase this report:
– The Market Forecast Sheet (ME) in Excel format
– 3 months analyst support
Read the full report: https://www.reportlinker.com/p06101229/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data, so you get all the market research you need instantly and in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Pigmentation Disorders Treatment Market - Growth, Trends, COVID-19 Impact and Forecast (2021 .)

Leave a Comment